Pancreatic Cancer Genes
AssigneeChiron Corporation, a Delaware corporation
InventorGiulia C. Kennedy
Life of this patent
Estimating the term…
Abstract
The present invention provides the art with the DNA coding sequences of polynucleotides that are up-or-down-regulated in cancer and dysplasia. These polynucleotides and encoded proteins or polypeptides can be used in the diagnosis or identification of cancer and dysplasia. Inhibitors of the up-regulated polynucleotides and proteins can decrease the abnormality of cancer and dysplasia. Enhancing the expression of down-regulated polynucleotides or introducing down-regulated proteins to cells can decrease the growth and/or abnormal characteristics of cancer and dysplasia.
Claims8
An isolated polypeptide comprising at least 6 contiguous amino acids:
- encoded by SEQ ID NO:15.
An isolated polypeptide comprising a first protein segment comprising at least 6 contiguous amino acids encoded by SEQ ID NO:15;
- and a second protein segment.
Dependencies are inferred from the claim text.